- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hims Hers Health Inc (HIMS)
The Hims Hers Health share price today is 33.78, view NYSE HIMS stock exchange data. Track the latest Hims Hers Health share price with real-time updates on HIMS stock performance including market cap, day range, 52-week range and dividend yield. Access HIMS charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
31.60
34.46
52 wk Range
13.74
65.30
HIMS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
31.6034.46
52 wk Range
13.7465.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HIMS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
30.85
Downside
-8.69%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
11 Hold
1 Sell
Ratings:
15 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 30.85
(-8.69% Downside)
Hims Hers Health Inc Earnings Call Summary for Q2/2026
- Q2 revenue surged 40% YoY to $753M, beating estimates by 8.9%, but EPS of -$0.37 missed forecasts by $0.32, triggering a 6.3% after-hours decline.
- Company raised full-year revenue guidance to $3.1B-$3.3B while maintaining adjusted EBITDA outlook at $275M-$325M despite margin pressure from expansion.
- Gross margin compressed to 64% from prior levels due to branded weight-loss products and international growth; negative free cash flow of $68M raised concerns.
- Subscriber base reached 3M after adding 300K in Q2; management emphasized AI integration and peptide product development pending FDA regulatory clarity.
- CFO cited working capital normalization expected to improve second-half cash flow; non-recurring charges of $81M from Eucalyptus acquisition weighed on results.
Last Updated: 11-08-2026, 03:52 am
Read Full TranscriptEarnings
Latest Release
10-08-2026
EPS / Forecast
-0.37 / -0.05
Revenue / Forecast
753M / 691.65M
Compare HIMS to Peers and Sector
Metrics to compare | HIMS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHIMSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −55.5x | −0.1x | −0.3x | |
PEG Ratio | 0.29 | 0.00 | 0.00 | |
Price/Book | 24.3x | 0.7x | 2.6x | |
Price / LTM Sales | 3.1x | 0.9x | 3.1x | |
Upside (Analyst Target) | −5.8% | 16.8% | 47.6% | |
Fair Value Upside | Unlock | 17.8% | 5.6% | Unlock |
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Hims Hers Health (HIMS) Share Price Today?
The Hims Hers Health share price today is 33.78.
What is the current Hims Hers Health (HIMS) share price and day range?
As of 22-08-2026, the Hims Hers Health share price is 33.78, with a previous close of 31.86. The share price has ranged from 31.60 to 34.46 today, while the 52-week range spans from 13.74 to 65.30.
What Is the Hims Hers Health Market Cap?
As of today, Hims Hers Health market cap is 7.43B.
What Is the Hims Hers Health (HIMS) Share Price Target?
The average 12-month share price target for Hims Hers Health is 30.85, with a high estimate of 42 and a low estimate of 23. 3 analysts recommend buying, while 1 suggest selling, with an overall rating of Neutral and -8.69% Downside potential.
What Is Hims Hers Health's Earnings Per Share (TTM)?
The Hims Hers Health EPS (TTM) is -0.62.
When Is the Next Hims Hers Health Earnings Date?
Hims Hers Health will release its next earnings report on 09-11-2026.
From a Technical Analysis Perspective, Is HIMS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Hims Hers Health Trade On?
Hims Hers Health is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Hims Hers Health?
The stock symbol for Hims Hers Health is "HIMS."
How Many Times Has Hims Hers Health Stock Split?
Hims Hers Health has split 0 times.
How Many Employees Does Hims Hers Health Have?
Hims Hers Health has 2442 employees.
What Is the HIMS Premarket Price?
HIMS's last pre-market stock price is 31.81. The pre-market share volume is 1,39,050.00, and the stock has changed by -0.05, or -0.16%.
What Is the HIMS After Hours Price?
HIMS's last after hours stock price is 33.80, the stock has changed by 0.02, or 0.06%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.